ClinicalTrials.gg
Enrolling by invitationNCT07790107Updated Aug 31, 2026

Behavioral Health Initial Intake Outreach

An interventional study of Pre-intake appointment informational messages in Behavioral Health, sponsored by Geisinger Clinic. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Geisinger Clinic · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
6,200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to help patients get seen sooner for behavioral health appointments by informing them about group therapy options, which allow more patients to be seen at once, often more quickly than 1:1 therapy. We will test whether messages describing the benefits of group therapy might encourage more patients to sign up for group therapy, thereby shortening patients' time to beginning therapy.

Read the detailed description

Before beginning any therapy, patients must complete an intake appointment, involving initial assessments and a determination of whether 1:1 or group therapy is appropriate for the patient. However, many patients are unaware that a group therapy recommendation (vs. 1:1 therapy) is a potential outcome of the intake appointment, and/or are unaware of the benefits of group therapy.

We will test whether messages informing patients about the benefits of group therapy sent ahead of the routine intake calls can increase the uptake of group therapy, helping patients get care sooner. Patients will be randomized to the message group or the no-message control group (i.e., current standard of care).

Patients in the message group will be sent messages soon after their intake appointment is scheduled. The messages will describe the goal of the visit ("Your upcoming visit is a one-time appointment to plan what's next for your care.") and emphasize the benefits of group therapy (e.g., "Groups usually start sooner than individual sessions and offer plenty of days and times to fit your schedule."), with a link to a flyer with more group-therapy details. The same information will be added to the patient instructions for the visit for those in the message group.

Messages will be sent via the MyChart patient portal for those with an existing MyChart account. Those who do not have MyChart but can be sent a text message will get a text message with a link to activate their MyChart account to view the patient instructions.

Patients will be enrolled for one year, with about 6200 expected in this time frame.

02

Conditions studied

  • Behavioral Health

Keywords

  • psychotherapy
  • patient education
  • randomized controlled trial
  • access to care
  • patient messaging
  • nudges
03

In context

Lead sponsor

Geisinger Clinic is the lead sponsor of 127 studies on the registry; 17 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 7 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Patient is age 18 years or older
  • Patient is referred for outpatient behavioral health psychotherapy services at Geisinger
  • Patient has a scheduled behavioral health intake appointment
  • Patient is eligible to receive pre-appointment messages through MyChart and/or SMS
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
6,200 participants (estimated)

Study arms

  • No intervention
    Usual Care

    Patients will receive usual care and will not receive the pre-intake call informational messages. Usual care includes the standard scheduling and communication processes for behavioral health intake appointments.

  • Experimental
    Pre-Intake Appointment Messages

    Patients will receive informational messages delivered through MyChart or text message before their scheduled behavioral health intake appointment. Patient instructions will also be modified.

    Behavioral: Pre-intake appointment informational messages

Interventions

  • BehavioralPre-intake appointment informational messages

    Informational messages delivered through MyChart or text message before a scheduled behavioral health intake call. The MyChart messages explain that the intake call is a one-time appointment to determine the most appropriate treatment plan, describe potential benefits of group psychotherapy, and provide a link to additional educational information about group therapy. Patient instructions with the same information added to the appointment within MyChart. Patients who do not have MyChart but can be sent text messages will get brief text messages with a link to MyChart to view patient instructions with information about group therapy.

06

What researchers measure

Primary outcomes

  1. Time to first psychotherapy appointment

    Time from the date the intervention message is sent (or the corresponding index date for patients assigned to usual care) to the patient's first completed psychotherapy appointment, whether group or 1:1

    Time frame: Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

Other outcomes

  1. Time to first group psychotherapy appointment

    Time from the date the intervention message is sent (or the corresponding index date for patients assigned to usual care) to the patient's first completed group psychotherapy appointment

    Time frame: Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

  2. Time to first 1:1 psychotherapy appointment

    Time from the date the intervention message is sent (or the corresponding index date for patients assigned to usual care) to the patient's first completed 1:1 psychotherapy appointment

    Time frame: Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

  3. Completion of psychotherapy appointment (y/n)

    Completion of a psychotherapy appointment, either group or 1:1

    Time frame: Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

  4. Completion of group psychotherapy appointment (y/n)

    Completion of a group psychotherapy appointment

    Time frame: Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

  5. Completion of 1:1 psychotherapy appointment (y/n)

    Completion of a 1:1 psychotherapy appointment

    Time frame: Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

  6. Behavioral health intake appointment completion (y/n)

    Completion of a behavioral health intake appointment

    Time frame: Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

  7. Time to first behavioral health intake appointment completion

    Time from the date the intervention message is sent (or the corresponding index date for patients assigned to usual care) to the patient's first completed behavioral health intake

    Time frame: Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

  8. Number of group therapy sessions attended

    Count of group therapy sessions attended

    Time frame: Within 1 year after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

  9. Behavioral health-related emergency department (ED) visits (y/n)

    Had at least one behavioral health-related ED visit

    Time frame: Within 1 year after the intervention message is sent (or the corresponding index date for patients assigned to usual care)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07790107
Lead sponsor
Geisinger Clinic
Responsible party
Gail Rosenbaum (Program Director, Geisinger Behavioral Insights Team, Geisinger Clinic) — Principal investigator
First posted
Aug 27, 2026
Start date
Aug 20, 2026 (estimated)
Primary completion
Mar 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Aug 31, 2026

Study contacts

Gail Rosenbaum, PhD
principal investigator · Geisinger Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion